Cocrystal Pharma Inc (COCP)
1.757
-0.05
(-2.94%)
USD |
NASDAQ |
Oct 31, 16:00
1.75
-0.01
(-0.39%)
After-Hours: 20:00
Cocrystal Pharma Net Income (Quarterly): -5.343M for June 30, 2024
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -5.343M |
| March 31, 2024 | -3.956M |
| December 31, 2023 | -4.464M |
| September 30, 2023 | -4.165M |
| June 30, 2023 | -4.166M |
| March 31, 2023 | -5.189M |
| December 31, 2022 | -4.501M |
| September 30, 2022 | -5.70M |
| June 30, 2022 | -24.43M |
| March 31, 2022 | -4.208M |
| December 31, 2021 | -3.685M |
| September 30, 2021 | -3.941M |
| June 30, 2021 | -3.821M |
| March 31, 2021 | -2.738M |
| December 31, 2020 | -1.493M |
| September 30, 2020 | -2.67M |
| June 30, 2020 | -3.495M |
| March 31, 2020 | -1.99M |
| December 31, 2019 | -47.84M |
| September 30, 2019 | -1.78M |
| June 30, 2019 | -1.515M |
| March 31, 2019 | 2.971M |
| December 31, 2018 | -44.29M |
| September 30, 2018 | -1.868M |
| June 30, 2018 | -1.343M |
| Date | Value |
|---|---|
| March 31, 2018 | -1.553M |
| December 31, 2017 | 5.197M |
| September 30, 2017 | -2.26M |
| June 30, 2017 | -1.002M |
| March 31, 2017 | -2.548M |
| December 31, 2016 | -65.75M |
| September 30, 2016 | -1.881M |
| June 30, 2016 | -3.227M |
| March 31, 2016 | -4.012M |
| December 31, 2015 | -30.45M |
| September 30, 2015 | -0.508M |
| June 30, 2015 | -2.623M |
| March 31, 2015 | -16.54M |
| December 31, 2014 | -1.907M |
| September 30, 2014 | -2.549M |
| June 30, 2014 | 4.73M |
| March 31, 2014 | -0.372M |
| December 31, 2013 | -0.794M |
| September 30, 2013 | -1.005M |
| June 30, 2013 | -1.03M |
| March 31, 2013 | -1.058M |
| December 31, 2012 | -3.505M |
| September 30, 2012 | -0.0987M |
| June 30, 2012 | -0.7144M |
| March 31, 2012 | -3.646M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
-47.84M
Minimum
Dec 2019
-1.493M
Maximum
Dec 2020
-7.252M
Average
-4.165M
Median
Sep 2023
Net Income (Quarterly) Benchmarks
| Perspective Therapeutics Inc | -11.70M |
| Alaunos Therapeutics Inc | -1.129M |
| Oragenics Inc | -2.305M |
| Cara Therapeutics Inc | -20.02M |
| Jaguar Health Inc | -9.492M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.448M |
| EPS Diluted (Quarterly) | -0.53 |
| Enterprise Value | 0.2716M |
| Earnings Yield | -101.1% |
| Normalized Earnings Yield | -122.66 |